RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling

被引:0
|
作者
Hu, Sheng [1 ]
Zhang, Yijie [2 ]
Qiu, Chenming [3 ,5 ]
Li, Ying [2 ,4 ]
机构
[1] Gen Hosp Western Theater Command, Dept Pulm & Crit Care Med, Chengdu, Peoples R China
[2] Gen Hosp Western Theater Command, Dept Geriatr, Chengdu, Peoples R China
[3] Gen Hosp Western Theater Command, Dept Burn, Chengdu, Peoples R China
[4] Gen Hosp Western Theater Command, Dept Geriatr, Chengdu 610083, Peoples R China
[5] Gen Hosp Western Theater Command, Dept Burn, Chengdu 610083, Peoples R China
关键词
RGS10; AKT; mTORC1; pulmonary arterial smooth muscle cell; pulmonary hypertension; MAMMALIAN TARGET; MTORC1; HYPERPLASIA; SUPPRESSES;
D O I
10.1080/10641963.2023.2271186
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Excessive proliferation and migration of pulmonary arterial smooth muscle cell (PASMC) is a core event of pulmonary hypertension (PH). Regulators of G protein signaling 10 (RGS10) can regulate cellular proliferation and cardiopulmonary diseases. We demonstrate whether RGS10 also serves as a regulator of PH.Methods: PASMC was challenged by hypoxia to induce proliferation and migration. Adenovirus carrying Rgs10 gene (Ad-Rgs10) was used for external expression of Rgs10. Hypoxia/SU5416 or MCT was used to induce PH. Right ventricular systolic pressure (RVSP) and right ventricular hypertrophy index (RVHI) were used to validate the establishment of PH model.Results: RGS10 was downregulated in hypoxia-challenged PASMC. Ad-Rgs10 significantly suppressed proliferation and migration of PASMC after hypoxia stimulus, while silencing RGS10 showed contrary effect. Mechanistically, we observed that phosphorylation of S6 and 4E-Binding Protein 1 (4EBP1), the main downstream effectors of mammalian target of rapamycin complex 1 (mTORC1) as well as phosphorylation of AKT, the canonical upstream of mTORC1 in hypoxia-induced PASMC were negatively modulated by RGS10. Both recovering mTORC1 activity and restoring AKT activity abolished these effects of RGS10 on PASMC. More importantly, AKT activation also abolished the inhibitory role of RGS10 in mTORC1 activity in hypoxia-challenged PASMC. Finally, we also observed that overexpression of RGS10 in vivo ameliorated pulmonary vascular wall thickening and reducing RVSP and RVHI in mouse PH model.Conclusion: Our findings reveal the modulatory role of RGS10 in PASMC and PH via AKT/mTORC1 axis. Therefore, targeting RGS10 may serve as a novel potent method for the prevention against PH."
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling
    Zhang, Shuai
    Wang, Jing
    Qi, Xianmei
    Tao, Xincao
    Xie, Wanmu
    Wan, Jun
    Shen, Ying H.
    Zhai, Zhenguo
    EXPERIMENTAL CELL RESEARCH, 2021, 398 (01)
  • [2] TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension
    Wang, Shuang
    Cao, Weiwei
    Gao, Shan
    Nie, Xiaowei
    Zheng, Xiaodong
    Xing, Yan
    Chen, Yingli
    Bao, Hongxia
    Zhu, Daling
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (11) : 1534 - 1545
  • [3] NCAM1 modulates the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary hypertension
    Chen, Yunwei
    Liu, Ningxin
    Yang, Yunjing
    Yang, Lingzhi
    Li, Yan
    Qiao, Zhuo
    Zhang, Yumin
    Li, Ailing
    Xiang, Rui
    Wen, Li
    Huang, Wei
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [4] Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension
    Kouri, Fotini M.
    Queisser, Markus A.
    Koenigshoff, Melanie
    Chrobak, Lzabella
    Preissner, Klaus T.
    Seeger, Werner
    Eickelberg, Oliver
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (09): : 1872 - 1882
  • [5] Simvastatin inhibits proliferation and migration of pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension
    Nakamura, Kazufumi
    Ikeda, Tetsuya
    Fujio, Hidelki
    Ogawa, Aiko
    Kobayashi, Kaoru
    Miura, Aya
    Miura, Daiji
    Nagase, Satoshi
    Fuke, Sochim
    Oka, Takefurm
    Mohri, Satoshi
    Kusano, Kengo F.
    Matsubara, Hiromi
    Miyazaki, Masahiro
    Date, Hiroshi
    Ohe, Tohru
    CIRCULATION, 2007, 116 (16) : 122 - 122
  • [6] Camkii Is Necessary For Increased Proliferation And Migration Of Pulmonary Arterial Smooth Muscle Cells In Pulmonary Hypertension
    Huetsch, J.
    Jiang, H.
    Shimoda, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling
    He, Yuhu
    Zuo, Caojian
    Jia, Daile
    Bai, Peiyuan
    Kong, Deping
    Chen, Di
    Liu, Guizhu
    Li, Juanjuan
    Wang, Yuanyang
    Chen, Guilin
    Yan, Shuai
    Xiao, Bing
    Zhang, Jian
    Piao, Linjuan
    Li, Yanli
    Deng, Yi
    Li, Bin
    Roux, Philippe P.
    Andreasson, Katrin, I
    Breyer, Rich
    Su, Yunchao
    Wang, Jian
    Lyu, Ankang
    Shen, Yujun
    Yu, Ying
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (10) : 1263 - 1276
  • [8] PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis
    He, Zhen
    Chang, Teding
    Chen, Yu
    Wang, Hongjie
    Dai, Lei
    Zeng, Hesong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [9] Halofuginone inhibits cell proliferation and AKT/mTORC1 signaling in uterine leiomyoma cells
    Lin, Jing
    Wu, Xiaochun
    GROWTH FACTORS, 2022, 40 (5-6) : 212 - 220
  • [10] Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension
    Zurlo, Giada
    Piquereau, Jerome
    Moulin, Maryline
    Da Silva, Julie Pires
    Gressette, Melanie
    Ranchoux, Benoit
    Garnier, Anne
    Ventura-Clapier, Renee
    Fadel, Elie
    Humbert, Marc
    Lemaire, Christophe
    Perros, Frederic
    Veksler, Vladimir
    JOURNAL OF HYPERTENSION, 2018, 36 (05) : 1164 - 1177